Return to work after surgical treatment for malignant pleural mesothelioma: report of a case

被引:0
作者
Masaru Takenaka
Yoshinobu Ichiki
Akihiro Taira
Shinji Shinohara
Taiji Kuwata
Ayako Hirai
Naoko Imanishi
Kazue Yoneda
Noriaki Tsubota
Fumihiro Tanaka
机构
[1] University of Occupational and Environmental Health,Second Department of Surgery, School of Medicine
[2] Kita-Harima Medical Center,Thoracic Surgery
来源
General Thoracic and Cardiovascular Surgery | 2019年 / 67卷
关键词
Malignant pleural mesothelioma; Pleurectomy/decortication; Incomplete resection; Maintenance chemotherapy; Long-term survival;
D O I
暂无
中图分类号
学科分类号
摘要
We report the case of a 56-year-old woman who underwent pleural biopsy to identify the cause of the right pleural effusion. The pathological diagnosis was epithelial malignant pleural mesothelioma. The patient worked as a junior high school teacher and strongly hoped for continuing work. Thus, we performed pleurectomy/decortication (P/D) as a curative surgery. The operative findings showed pleural thickening that in the lower lobe of the lung. Thus, peeling of the lower lobe was performed. Pleural biopsy was only performed on the upper and middle lobes. As a result, the operation was limited P/D. The pathological findings showed a small number of mesothelioma cells in the upper and middle lobes. The patient received four courses of cisplatin plus pemetrexed systemic chemotherapy after surgery. Continuous maintenance chemotherapy using pemetrexed has been performed until the time of writing. At present, she has continued her work for 6 years after the operation and has extended her retirement age without recurrence.
引用
收藏
页码:897 / 900
页数:3
相关论文
共 48 条
[1]  
Mancuso MR(2017)Novel sustemic therapy against malignant pleural mesothelioma Transl Lung Cancer Res 6 295-314
[2]  
Neal JW(2007)Extrapleural pneumonectomy is the preferred surgical management in the multimodality therapy of pleural mesothelioma: con argument Ann Surg Oncol 14 1249-1253
[3]  
Cameron RB(2011)Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the mesothelioma ond radical surgery (MARS) randomized feasibility study Lancet Oncol 12 763-772
[4]  
Treasure T(2012)Initial analysis of the international association for the study of lung cancer mesothelioma database J Thorac Oncol 7 1632-1639
[5]  
Lang-Lazdunski L(2008)Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients J Thorac Cardiovasc Surg 135 620-626
[6]  
Waller D(2018)New perspectives on diagnosis and therapy of malignant pleural mesothelioma Front Oncol 8 91-658
[7]  
Bliss JM(2018)Non-incisional pleurectomy-decortication for malignant pleural mesothelioma Surg Today 48 656-2351
[8]  
Tan C(2014)Long progeression-free survival by pemetrexed continuation maintenance thrapy following cisplatin-based chemotherapy in malignant pleural mesothelioma Intern Med 53 2347-undefined
[9]  
Entwisle J(2016)Pemetrexed maintenance therapy following bevacizumab-containing first-line chemotherapy in advanced maliganant pleural mesothelioma Medicine 95 e3351-undefined
[10]  
Rusch VW(2018)A phase II trial of first-line combination chemotherapy with Cisplatin, Pemetrexed, and Nivolumab for unresectable malignant pleural mesothelioma: a study protocol Clin Lung Cancer 19 e705-7-undefined